Nature Communications · 2021 · 91 citations · 69 references
MedicineOncologyPharmacologyCancer PharmacologyCell SignalingMolecular PharmacologyHormonal Cancer TherapyHormonal TherapyLung TargetingSteroid Hormone SignalingAdvanced Prostate Cancer TherapyAndrogen Receptor ExpressionAndrogen Receptor RegulationAndrogen Receptor TargetingAndrogen ReceptorsCell Surface ProteinsProstate Cancer Hormonal TherapySars-cov-2 Infection
SARS-CoV-2 attacks various organs, most destructively the lung, and cellular entry requires two host cell surface proteins: ACE2 and TMPRSS2. Downregulation of one or both of these is thus a potential therapeutic approach for COVID-19. TMPRSS2 is a known target of the androgen receptor, a ligand-activated transcription factor; androgen receptor activation increases TMPRSS2 levels in various tissues, most notably prostate. We show here that treatment with the antiandrogen enzalutamide-a well-tolerated drug widely used in advanced prostate cancer-reduces TMPRSS2 levels in human lung cells and in mouse lung. Importantly, antiandrogens significantly reduced SARS-CoV-2 entry and infection in lung cells. In support of this experimental data, analysis of existing datasets shows striking co-expression of AR and TMPRSS2, including in specific lung cell types targeted by SARS-CoV-2. Together, the data presented provides strong evidence to support clinical trials to assess the efficacy of antiandrogens as a treatment option for COVID-19.
69
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou, Xing‐Lou Yang, Xian-Guang Wang et al. · Nature · 2020 · 23.3K citations · Full text
An integrated encyclopedia of DNA elements in the human genome